State of Wyoming Acquires 6,132 Shares of Progyny, Inc. (NASDAQ:PGNY)

State of Wyoming lifted its holdings in shares of Progyny, Inc. (NASDAQ:PGNY) by 98.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 12,376 shares of the company’s stock after purchasing an additional 6,132 shares during the period. State of Wyoming’s holdings in Progyny were worth $213,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in PGNY. Barclays PLC lifted its stake in shares of Progyny by 530.4% during the third quarter. Barclays PLC now owns 706,157 shares of the company’s stock valued at $11,835,000 after acquiring an additional 594,140 shares during the period. Ballentine Partners LLC acquired a new position in shares of Progyny during the fourth quarter valued at $187,000. Nisa Investment Advisors LLC lifted its stake in shares of Progyny by 108.4% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company’s stock valued at $51,000 after acquiring an additional 1,526 shares during the period. Janney Montgomery Scott LLC acquired a new position in shares of Progyny during the fourth quarter valued at $1,124,000. Finally, KBC Group NV lifted its stake in shares of Progyny by 84.6% during the fourth quarter. KBC Group NV now owns 4,669 shares of the company’s stock valued at $81,000 after acquiring an additional 2,140 shares during the period. Institutional investors own 94.93% of the company’s stock.

Progyny Stock Down 1.8%

PGNY stock opened at $20.52 on Friday. The business has a 50 day moving average price of $22.15 and a two-hundred day moving average price of $19.96. The company has a market cap of $1.76 billion, a price-to-earnings ratio of 35.38, a P/E/G ratio of 2.39 and a beta of 1.37. Progyny, Inc. has a twelve month low of $13.39 and a twelve month high of $30.42.

Progyny (NASDAQ:PGNY) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.28). The company had revenue of $324.04 million during the quarter, compared to the consensus estimate of $307.86 million. Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm’s revenue for the quarter was up 16.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.17 earnings per share. On average, equities research analysts anticipate that Progyny, Inc. will post 0.6 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Bank of America upped their price target on Progyny from $21.00 to $25.00 and gave the company a “buy” rating in a research note on Tuesday, February 11th. Canaccord Genuity Group cut their target price on Progyny from $23.00 to $21.00 and set a “hold” rating on the stock in a research note on Monday, May 12th. BTIG Research raised Progyny from a “neutral” rating to a “buy” rating and set a $28.00 target price on the stock in a research note on Monday, March 31st. Finally, JPMorgan Chase & Co. increased their target price on Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a research note on Tuesday, January 28th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Progyny has an average rating of “Hold” and a consensus price target of $23.45.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.